Interventional Cardiology Solution Introduced Simultaneously in Opposite Parts of the World
Alphenix / Evolve Edition is a new imaging solution from Canon Medical Systems for interventional cardiology suites. It utilizes real-time Deep Learning technology to help clinicians reduce the X-ray dose and contrast media usage while maintaining high image quality. Its technologies, which are packaged as Evolve Technology, assist with daily interventional cardiology procedures, and elevate clinical confidence and procedural efficiency.
On August 4 to 6, in conjunction with the 31st Annual Meeting of the Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT 2023) in Fukuoka, Japan, Canon conducted the release of the new X-ray angiography system.
Around the same time, Canon also actively conducted promotional activities in SOLACI (Sociedad Latino Americana de Cardiologia Intervencionista) for Alphenix / Evolve Edition in Brazil for customers in Central and South America.
SOLACI is the Latin American Society of Interventional Cardiology's largest cardiovascular medicine meeting in Central and South America. This meeting was held with the Brazilian Society of Hemodynamics and Interventional Cardiology (SBHCI), Brazil's largest cardiovascular medicine meeting, in Rio de Janeiro, Brazil, from August 2 to 4, 2023.
As part of the global launch events for Alphenix / Evolve Edition, Canon presented an exhibition booth at the conference and cohosted a lunch symposium to promote the system in Central and South America.
The symposium was held on the first day of SOLACI and tackled the topic: "Elevate the Interventional Cardiology Procedure with Artificial Intelligence." The session explored the clinical benefits of Canon's first, real-time AI processing technology, as incorporated in Alphenix / Evolve Edition.
Dr. Ari Mandil of Hospital Felício Rocho (one of the “World's Best Hospitals" according to the Newsweek Magazine) Chaired the event. He is a leading figure in Brazil's Cardiovascular Society and was the President of SBHCI 2022. Dr. Mandil moderated the symposium to encourage lively discussions about the clinical values of Canon latest technologies.
At this event, we invited international speakers to promote Alphenix / Evolve Edition and help transform the cardiovascular market in Central and South America. As a result, we could demonstrate the full potential of Canon latest technologies.
Canon will continue working as a true solutions provider in Cardiology in Central and South America.
The content reflects information available at the time of publication and may differ from current information.
Read testimonials from users of Canon Medical Systems' vascular systems.